Analysis of electronic health data from nearly 100 million people confirms that the benefits of COVID-19 vaccines far outweigh the risks, even after identifying two new, extremely rare neurological side effects. Researchers used anonymized information to compare disease rates with pre-pandemic expectations, validating known associations such as myocarditis and Guillain-Barré syndrome, while also detecting acute disseminated encephalomyelitis and transverse myelitis in very specific cases. The massive scale of this study enables the discovery of adverse reactions that are statistically unlikely to be detected in traditional clinical trials, which have smaller sample sizes. Although the new findings underscore the need for ongoing surveillance, experts emphasize that the risk of developing these serious complications is significantly higher from natural infection than from vaccination. This demonstrates that post-marketing surveillance systems are effective at detecting and responding to safety issues that emerge when vaccines are administered on a large scale. This work is crucial for the field of open data because it illustrates how the use of large volumes of anonymized data can safeguard public health and maintain trust in global health. By showing that systems can quickly identify and address rare risks, it validates the transparency and rigor of real-time data analysis. The ability to scale research using real-world data is an essential pillar for justifying evidence-based public health policies and strengthening the credibility of vaccination campaigns among the public.
Source:Published on 2024-02-27
Related news
- Llama INAI a garantizar protección de datos personales y privacidad en el uso de celulares | El Universal
- Estas son las predicciones de Deloitte para la industria tecnológica, IA y sostenibilidad en 2024
- El 9,3% de los hogares de Castilla-La Mancha admite que llegó "con mucha dificultad" a fin de mes durante 2023
- Información pública sobre funcionarios sigue oculta - Política - ABC Color